According to the Pet Food Manufacturers Association, there are an estimated 1M pet rabbits in the UK. They are commonly presented for treatment in practice and clients are beginning to expect complex workups and high levels of veterinary care.
Ivan, who qualified from the RVC in 1999, has been taking on first and second opinion rabbit cases for over 12 years and was instrumental in developing the v-gel anaesthetic device for rabbits and other species (www.docsinnovent.com). Jo has worked in first opinion practice since 2007 and was the Blue Cross Veterinary Nurse of the Year in 2014. Asides from her nursing experience, Jo has been teaching rabbit husbandry and nursing to owners and nurses directly and also via the Rabbit Welfare Association since 2012. Jo and Ivan have also taught rabbit anaesthesia at the Western Veterinary Conference in the USA for the last 3 years as well as lecturing for the Rabbit Welfare Association in the UK.
Ivan said: "We’re trying to get rabbit medicine to be seen as an important CPD subject for vets and nurses. We’re going to be offering day courses and conferences with an enjoyable and challenging mix of small group teaching, problem solving, practical teaching and conventional lectures - making sure that all our courses offer a really enjoyable day out as well as being first class CPD. Our first course is on the 13th October in Berkshire and we’ll be offering many more courses and conferences in the future!"
For more information about LagoLearn and its rabbit CPD, visit: http://www.lagolearn.com
The AHT has secured an award of £580,000 from the Wellcome Trust to fund the development of a new diagnostic test for Strangles which takes only 30 minutes.
It's been achieved in part by 'Breaking the Strangles Hold' - a two-year fundraising campaign run by the Animal Health Trust (AHT) and The British Horse Society (BHS),
Money donated from the general public, along with funding from The Horse Trust, has already allowed scientists at the AHT to develop a diagnostic blood test which gives results in 24 hours. The blood test was launched in February 2008 and since then more than 6,700 samples have been tested.
HRH The Princess Royal, who launched the 'Breaking the Strangles Hold' campaign, said: "As an owner who has seen my own horse's affected by this terrible disease, it's wonderful to see such progress being made in a relatively short time.
"The screening test enables owners to know within 24 hours if any of their horses have been exposed to this bacterium. Previously available tests would have taken three to four days. The test is making a real difference in welfare and economic terms for all those involved in the equine industry. It truly is groundbreaking."
The success of this diagnostic work, along with other AHT research, has attracted further funding for the project from the Wellcome Trust in the form of a £580,000 Translation Award.
Professor Andrew Waller, Head of Bacteriology at the AHT, said: "The main problem with Strangles is the time taken to diagnose it. The current blood test is a big step forward, but the culture and DNA tests, which are often used in the initial stages of an outbreak can take a couple of days to get results."
The Translation Award means the AHT can reduce the time taken to perform its DNA diagnostic test and ultimately produce a point-of-care test that vets can use on site to get a diagnosis in 30 minutes. Earlier diagnosis will allow owners to isolate horses sooner and minimise the spread of infection. It will further reduce welfare problems for horses and the cost to their owners.
The AHT and Atlas Genetics will design and validate the point-of-care diagnostic test over the next two years. It is hoped that the test could be mass produced and widely available by 2012.
Professor Waller added: "This technology will be fantastic. It will be hugely beneficial for other diseases too, of both veterinary and clinical importance. Without the money raised through the 'Breaking the Strangles Hold' campaign, we wouldn't have made as much progress. On behalf of horses and horse owners worldwide, I'd like to thank everyone who has donated."
The 'Breaking the Strangles Hold' campaign reached its fundraising target of £250,000 in just two years, demonstrating how important to horse owners it is to get to grips with this terrible disease.
For more information, see: http://www.strangles.org
The new service will offer all the chemo and surgical options.
Matthew (pictured right) said: "At Eastcott, we have amazing facilities and staff to care for pets with cancer, so we are proud to launch this comprehensive new oncology service.
"We have a custom-designed chemotherapy room, multiple sterile theatres - including our interventional radiology theatre - and state-of-the-art imaging facilities, with a 64-slice CT scanner and advanced ultrasound equipment.
"We are able to manage the full range of tumour types including maxillofacial tumours, from diagnosis to treatment.
"We use a variety of techniques to allow accurate staging, including minimally invasive biopsy and lymph node harvesting, as well as sentinel lymph node mapping and advanced medical imaging.
"Treatment options include advanced soft tissue surgical oncology and the full range of medical oncology. This may involve standard and metronomic chemotherapy, intracavitary chemotherapy and immunotherapy, such as the melanoma vaccine.
"We pride ourselves on helping owners understand our treatment plan through the whole process and emphasise the importance of making the right decisions to maintain the welfare of our patients.”
For more information, visit www.eastcottreferrals.co.uk.
Pet insurer esure has released the results of a survey of vets bills, carried out amongst 3000 pet owners.
Whilst the intent behind surveys like these may be laudable (i.e. to encourage more pet owners to insure their pets), they do the profession no favours, emphasising the high perceived costs of veterinary care rather than the good value that it generally represents.
This survey highlighted that:
esure's research showed that English Setters are the mostly costly breed of dog, forcing their owners to shell out £6,955 on vet bills, including injections, surgery and emergency treatments, in a lifetime.
Despite the potential for big bills, just a third (31 per cent) of pet owners have pet insurance and almost a quarter of those with cover admitted they were considering cancelling it to save money during the current credit crunch.
According to esure, many dog owners may be choosing to cancel or not even buy pet insurance because they are significantly underestimating the cost of treating common ailments and injuries. 29 per cent of pet owners surveyed think that the average vet bill for a dog with diabetes would be under £200, when it is actually £1146 including ongoing treatment*. To repair a dog's broken leg, 11 per cent of pet owners think that the average vet bill would be less than £100. It is actually more than five times that amount at £560*.
Mike Pickard, Head of esure pet insurance said: "Sickness, injury and long-term illness can affect any breed of dog, at any time, which is why it's crucial for pet owners to have insurance or ample savings to cover an unexpected vet bill of any size. With many pet owners underestimating the cost of treatment for common ailments, a hefty vet bill may stretch household finances to the limit - especially in the current credit crunch. Pet owners should plan ahead for all eventualities when it comes to their dog's health."
VET BILLS FOR THE TOP 10 MOST POORLY DOG BREEDS:
* Based on all claims received by pet insurance specialist, Thornside in 2008. http://www.bdml.co.uk/about-thornside.html
The Prime Minister's website has received a petition for a new law making it compulsory to microchip pets in the UK.
If you wish to support this petition, please click here and add your name: http://petitions.number10.gov.uk/MicrochipPets/
The full petition reads:
"I am a responsible pet owner and have both my parrots and dog microchipped. I genuinely believe that all pets (where possible) should be microchipped.
I feel that it should be mandatory and is part of being a responsible pet owner. This should act as a "licence". I strongly beleive that this course of action will protect many discarded, stolen and mistreated pets every year as there will be no escape for the owners as the pet can be traced back to them.
I appreciated that due to size and temperament some pets may not be able to be microchipped, but certainly dogs, cats, horses, valuable / larger birds, rabbits etc should be.
I hope you agree that £30 for a microchip is good value, if owners cannot afford this then they shouldnt be considering a pet in the first place.
Please can you give this idea serious consideration as I feel we must do something to protect the pets that do not have a voice in our society."
The BBC reports that a new strain of MRSA has emerged in British cows and is thought to be infecting humans.
For more on this story, click here.
Petplan is calling for nominations for this year's 'Petplan Pet Insurance Advisor Award'.
The award is to recognise the hard work and dedication that Pet Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially. You can nominate a PIA at your practice by visiting www.petplan.co.uk/pia. The winner will receive a new laptop and their practice will receive £100 in vouchers.
Petplan Marketing Manager Alison Andrew said: "At Petplan we are proud to recognise the dedication and hard work that Pet Insurance Advisors put in to give their customers informed and up-to-date advice. So please get your nominations in!"
Nominations close on 3rd September and the nominees will be judged by industry professionals. The winner will be announced at the annual BVNA Congress on 9th October.
Boehringer Ingelheim Vetmedica has announced that it will be launching Bovela, a new viral diarrhoea (BVD) vaccine, to farmers during April 2015.
Allan Henderson from Boehringer said: "BVD remains the most common viral disease affecting cattle throughout Europe, despite vaccines being available for over 15 years. We asked farmers why this was the case and, without exception, they remarked that current vaccine protocols are unwieldy, requiring precise timings making them hard to follow.
"Bovela is a unique one-shot vaccine that can be used in cattle from three months of age and also whether pregnant or not. Other, currently available vaccines require a two-dose primary course with boosters annually or even every six months thereafter."
BVD is spread within herds and to new herds through the presence of persistently infected (PI) animals. PIs can look relatively healthy and show no outward signs of infection but, as they were exposed to the virus as a foetus, have become virus carriers. If they are born alive, they will shed virus consistently throughout their lives so perpetuating the cycle of infection.
Alan said: "The foetal control delivered by Bovela gives absolute confidence that cows will not produce PIs. This, alongside the drastically improved convenience will undoubtedly make Bovela the natural choice for many farmers, both on beef and dairy farms."
According to Boehringer, around 60% of cattle in the EU test positive for exposure to the BVD virus and, although BVD type 1 is currently the most common form, outbreaks of BVD type 2, were confirmed in 2013 and 2014 in Belgium, Germany and The Netherlands. BVD type 2 is generally a more serious disease, with high levels of mortality and while the virus has been identified in UK, it has not yet been identified as the cause of serious outbreaks of disease in cattle.
Alan said: "Bovela is the first and only vaccine in UK which has been proven to protect cattle from BVD type 1 and 2. It has been in development for 17 years and, gained a marketing authorisation following assessment of an unprecedented quantity of data generated in both beef and dairy herds.
"Work has looked at the efficacy of Bovela in preventing the production of PI calves and against type 1 and 2 BVD as well as confirming its efficacy in young calves as young as three months of age as their natural maternal protection wears off. Trials also confirmed vaccine safety generally and during various stages of pregnancy. We do not believe that any other BVD vaccine has been tested as rigorously."
Vet Sustain works to inspire and enable veterinary professionals to become leading forces in sustainability and improve the health and wellbeing of animals, people and the environment.
To that end, the company produces tools, training and communications for veterinary professionals centred around its six Veterinary Sustainability Goals (SDGs):
Gudrun Ravetz, Chair and Director of Vet Sustain, said: “We are very pleased to announce IVC Evidensia as a strategic partner of Vet Sustain.
"Veterinary professionals sit at the One Health triumvirate of people, planet and environment every day and working with IVC Evidensia will allow Vet Sustain to continue work on ambitious projects to support veterinary professionals to be active sustainability champions.”
You can find out more about IVC's Sustainability Report here: https://ivcevidensia.com/how-we-work/sustainability/
Some big names from the art and entertainment worlds, including Cheryl Cole, Tracey Emin, Twiggy and Jamie Oliver are donating their own paintings and drawings of hares to raise money for two new operating theatres at Great Ormond Street Hospital.
One of these A4 canvases would be a great addition to a veterinary practice waiting room. It would be sure to create an interesting talking point, particularly if you specialise in leporids.
If you're interested in buying one, they go under the auctioneer's hammer both online and at the 'Hare Ball' at the Dorchester Hotel in London on May 26th 2011.
The Hare Styling Celebrity Canvases Appeal is the brainchild of hairdresser Michael Van Clarke whose daughter Angelica was given a lifesaving operation at Great Ormond Street Hospital when she was just two days old. Now 15 years old, Angelica has drawn a hare to help raise funds for the hospital that saved her life. The hare has been reproduced on A4 canvases which have been sent to well-known names in the public eye inviting them to create an original artwork.
Other celebrities who have already donated include Stella McCartney, Tara Palmer-Tomkinson, Terry Venables and HRH Princess Beatrice The Duchess of York. Many more are expected ahead of the March deadline. All of the canvases will be displayed at a central London gallery exhibition and most will be included in a hard bound book printed to raise further money for Great Ormond Street Hospital Children’s Charity.
Michael Van Clarke said: “The pioneering work carried out at Great Ormond Street Hospital provides hope to extremely sick children and their families. My family knows first-hand the incredible difference the hospital can make and I am always looking for ways to show my gratitude. When we first came up with this Hare styling idea, we weren’t sure how it would be received, but we have been overwhelmed by the response from the recipients of the canvases.
"The fundraising potential of these canvases is huge and we are so grateful for the time and effort people have put in to creating them. We are also looking forward to handing over a big cheque to the charity once all the canvases have been sold.”
For further information or to see a selection of the canvases, please visit http://www.harestyling.com/.
Norbrook has launched palatable pork liver flavoured Carprieve tablets to help make dosing dogs a stress-free experience for dog and owner.
Offering Cox-2 preferential pain release, Carprieve Flavoured Tablets are indicated for chronic inflammation, such as degenerative joint disease in dogs, as well as post-operative pain management. According to Norbrook, tests have shown 75 per cent of dogs will take them voluntarily.
Sascha van Helvoort MRCVS, international veterinary adviser for Norbrook Laboratories, said: "Palatability is an important consideration for owners, especially for dogs with chronic inflammation, who often need regular tablets.
"Success is often hit-and-miss, with dogs leaving tablets given in food or spitting them out. This led to us testing pork liver tasting carprofen tablets on dogs who needed treatment, and the vast majority ate them from a bowl. This means vets can prescribe them with all confidence that the dogs will get their medicine.
Sascha added: "Studies undertaken by Norbrook covered a wide range of breeds, and included dogs from one year old to 14. In addition, the majority preferred the Pork liver flavour to top brand 'palatable' tablets.
"Getting the dosage right is also easy. That's why we decided to introduce our Carprieve Flavoured Tablets in blister packs rather than in tubs to aid dosage administration."
For more information, visit: http://www.norbrook.co.uk
Ceva Animal Health has launched PRID Delta, described as an improved intra-vaginal progesterone device for the synchronisation of oestrus in cycling and non-cycling cattle.
The company says it has used its 35 years of expertise in cattle fertility to develop PRID Delta, and that trials have demonstrated that the new device provides optimal progesterone release, preserved efficacy and high retention rates.
Ceva claims the special triangular shape and bi-material fabric of PRID Delta ensures maximum contact with vaginal mucosa to release optimal levels of progesterone at insertion and during treatment. The new PRID Delta continues to give a bigger progesterone peak after insertion as with the original PRID.
According to the company, clinical and field trials observing oestrus occurrence and fertility at fixed time artificial insemination have shown a preserved efficacy for PRID Delta. PRID Delta is licensed for oestrus synchronisation in both cycling and non cycling cows. It is licensed for fixed time AI. Trials have also confirmed that PRID Delta is quick and easy to insert, is well tolerated and has a retention rate of over 97%.
Ceva has recently introduced a new website www.reprology.com/ for technical advice on the best solutions for the management of cattle reproduction. For further information contact your Ceva sales representative or Ceva Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at www.ceva.uk.com/
The course is comprised of a 14-module programme of lectures, case discussions and practical sessions, during which Improve says delegates will learn how to approach the dog, cat and exotic patient presenting with manifestations of oral pathology in a logical and scientific manner.
Lecturers for the programme, which starts in January 2020, include Bob Partridge and Rachel Perry (pictured right), both European and RCVS Specialists in Veterinary Dentistry, and Owen Davies, an RCVS Specialist in Veterinary Oncology.
Each module will be supported with an online learning management platform offering additional learning resources, together with a subscription to Harper Adam’s online e-library which gives access to scientific articles and abstracts for those progressing to a PgC. All delegates have a dedicated Programme Tutor.
Juliet Pope, Operations Manager at Improve International, said: "The diagnosis and management of dental and oral disease is a significant – and growing - component of small animal practice.
"The programme we have developed offers a thorough case-based approach and includes the opportunity to practice oral surgery in a wet-lab environment.
"It will support general practitioners in taking a more well-informed clinical approach to the diagnosis and treatment of these cases and give them confidence to manage some cases that they might otherwise have felt they should refer."
Maeve Cuffe, Junior Brand Manager of large animal products, at Forte Healthcare Ltd said: “As dairy herds increase in size, routine fertility visits result in larger numbers of cows requiring prostaglandin treatment.
"Also, some vets now recommend two shots of prostaglandin instead of one in certain synchronisation protocols.
"The 25 dose presentation of Genestran is a great addition to the range, helping vets keep enough prostaglandin in stock, while minimising waste.”
Genestran 50ml is available in all veterinary wholesalers now.
Technical questions about Genestran should be sent to: vets@fortehealthcare.com
Medivet senior partner Adi Nell says the profession needs to consider new business models to encourage more vets into ownership, as well as fresh approaches to supporting the role.
Responding to issues and recommendations highlighted in the latest VetFutures report, such as the number of female practice owners and a perceived lack of business skills in the profession, Adi said practices need to be flexible when it comes to attracting new vets or owners.
"Client expectations have changed drastically in the past 15 years, but so have the desires of potential practice owners. The world of clinical practice is changing at a rate we’ve never seen before. Owning a practice, along with the other increasing demands on our limited time and energy, is becoming more of a challenge too. This is evident with the growth of business support and development services, indicating an increased demand for that support.
"New practice owners aren’t like previous generations. Although traditional models of ownership are changing gradually, we also need different models of working, such as flexible hours, and different methods of support are needed."
One of the trends noted in the 2014 VetFutures report was how, despite dominating the profession in terms of overall numbers, women are still less likely to be a sole principal, director or partner.
Medivet claims an excellent track record here, with a near 50/50 split of male and female branch owners/partners.
Adi added: "We’re very happy to have so many women as business partners with us. The combination of clinical freedom, business support and a real feeling of teamwork and care for each other are some of the features that enable our partnership model to work so well. The scope for clinical and business development is huge, and we do our very best to look after all our people as they grow.
"However, there are still far too many bright, talented and highly trained vets leaving the profession after too short a time. Why do we turn these diamonds into coal? We need to understand what’s driving this and how we can adapt. The VetFutures report starts to offer some of the answers – and has uncovered even more questions!"
The VetFutures report also found aspirations of practice ownership or partnership dropped from 45% among students to 25% once vets start work. Adi says that offering opportunities for vets to expand into other areas of expertise is key to reducing the decline in appetite for practice ownership. He said: "I started out offering dermatology referral services to various Medivet branches before becoming a branch partner myself. I’m now in charge of a Medivet region of 16 practices as well as being involved in strategy, marketing, HR and operations, which I absolutely love, but never predicted I would do.
"I believe fewer and fewer vets see themselves doing the same job in clinical practice for their entire careers. That includes not wanting to be an employee for life, but also not wanting to have all the responsibility and burden of individual practice ownership. A big group like Medivet allows them to find the niche they enjoy and to develop the skills they value, to the benefit of their own careers, their business success, their client care and their patients’ health."
The Crafty Vet Project aims to ignite your interest in one of a range of creative hobbies, which include cheese, beer, candle, soap and teddy-bear making, with kits available for sale from the new 'Craft Corner' section of their website. £3 from the sale of each kit will go to Vetlife.
Sarah said: "We wanted other veterinary professionals to experience the same pleasure that we get from creative hobbies. It is a chance for people no matter what day you have had to switch off, follow a pattern or instructions and come out with something at the end that you can be truly proud of."
Your new hobby might even turn into a nice sideline business. Sarah said: "One evening over a catch-up Zoe and I were discussing items that we wished we had in practice to make our lives as nurses easier.
"Despite having drunk 2 bottles of wine together we felt that there and then was the best time to start our new business. Two hours later having chopped up an old pair of curtains, accidently sewn my jumper sleeve into the material and woken my husband up at 3am to our cackles, we had the first prototype of our Slumberpet Recovery Coat.
"Our business has grown nicely since then and we are still coming up with more ideas, albeit in a slightly more sober, professional manner."
To select and order your hobby kit, visit: https://www.vnpetproducts.co.uk/craft-corner
The company is encouraging owners to post a simple 'thank you' on Facebook with the hashtag #thankuvets.
Boehringer has also produced a thank you video, depicting a day in the life of an equine vet during these tough times.
Warren Ball, Equine Brand Manager at Boehringer Ingelheim Animal Health, said: “This year has been a year like no other, but equine vets throughout the country have carried on regardless of the challenges they face and are deserving of a huge thanks from all who need them.”
"Our ‘Thank You Vets’ initiative will show how appreciated each and every vet is by bringing together owners, trainers and others in the equine community."
To watch the video and see the thank you messages from owners, visit: https://www.facebook.com/equitopmyoplast/posts/2188633904615007
What a lovely initiative. Makes a change from the usual griping on Facebook.
CEVA Animal Health and the University of Lincoln have presented three distance learning students on the university's pheromone therapy course with awards in recognition of their research into the benefits of pheromone therapy in combating behavioural problems in pets.
Veterinary nurse, Mandy Davis RVN, won first place and was presented with a cheque for £1,000 for her evaluation of the use of rabbit appeasing pheromones in a pet demonstrating fearful and aggressive behaviour towards its owner.
Second place and a cheque for £500 went to pet behaviourist and VetSurgeon member, Dr Carri Westgarth BSc(Hons) PhD from the University of Liverpool, for her case which reported on the use of D.A.P.® and clomipromine in a separation-related problem in a dog.
Third place and a cheque for £250 was awarded to veterinary surgeon, Graeme Buchan BVMS MRCVS, from Blackness Veterinary Centre in Dundee for his study into the use of a D.A.P.® Collar in the management of disruptive stress in the home.
"More and more pets are referred to animal behaviour experts each year and pheromone therapy is increasingly being used to help pets overcome behavioural issues such as aggression and separation anxiety," said Professor Daniel Mills, recognised specialist in veterinary behavioural medicine, at the University of Lincoln. "The students' case histories demonstrated their understanding of the benefits of pheromone therapy and how products that mimic the effects of naturally occurring pheromones can improve both the health and welfare of stressed pets. Many of the reports were of a very high standard, and showed a good understanding of the science behind the practice, which is so important for effective use."
The University of Lincoln launched the country's first accredited course in pheromone therapy in 2007 to help increase the veterinary profession's understanding of stress and its potential to trigger behavioural issues in pets. The distance learning course, which is supported by CEVA Animal Health, is aimed at veterinary surgeons, veterinary nurses and behaviourists and comprises 12 audio visual tutorials covering pheromone therapy and its applications in companion animals which can be undertaken at a pace to suit individual students.
Lucy Brett, product manager at CEVA Animal Health said: "The pheromone therapy course is a must for veterinary professionals wishing to learn more about behavioural problems in pets, including the stress triggers that can lead to disruptive and undesirable behaviour and the benefits of synthetic copies of natural pheromones in overcoming these issues."
The deadline for applications for the University of Lincoln's next Pheromone Therapy Course, which starts in February 2009, is 16 December 2008. For further information, please contact the University of Lincoln on 01522 882000 or visit www.lincoln.ac.uk.
Hill's Pet Nutrition is running an interesting prize draw to highlight a recent study which shows that by using Hill's Prescription Diet Feline c/d Multicare, sterile struvite uroliths can be dissolved in as little as 14 days.1
Send a canine or feline urolith for analysis at the Minnesota Urolith Center by the end of June, and you'll be entered into the draw to win a sparkling diamond worth £2000 (or €2000 in the Republic of Ireland. And no, Hill's hasn't explained why it's a cheaper rock up for grabs in Ireland).
You can download a form at www.hillspet.co.uk/urolith or www.hillspet.ie/urolith to send along with the uroliths.
Almost 80 percent of veterinarians polled on-line recently, used dietary means, either all or some of the time to treat FLUTD.2 It has been suggested that stones account for just 10 percent of non-obstructive and 15 percent of cases of obstructive FLUTD.3
Hill's says that along with its ability to dissolve sterile struvite stones in as little as 14 days, Hill's Prescription Diet Feline c/d Multicare dry pet food also has high levels of omega-3 fatty acids that help to break the cycle of inflammation and reduce discomfort in cats with FIC, making it an appropriate choice in most cases of FLUTD.
References
The original survey was sent last year to more than 5,000 UK-registered veterinary surgeons and veterinary nurses who gained their qualification from a non-UK EU institution, with a response rate of around 55%.
This year the Institute for Employment Studies (IES), on behalf of the RCVS, contacted over 6,000 veterinary surgeons and almost 50 veterinary nurses – including those previously surveyed as well as EU registrants who have joined since the last survey – who trained in non-UK EU countries to seek their views on the implications of Brexit for European veterinary professionals.
Chris Tufnell, RCVS Senior Vice-President and Chair of the College’s Brexit Taskforce, said: "The aim of this survey is to gain a greater understanding of the views and expectations of our EU colleagues now that certain elements of the UK’s withdrawal process from the European Union, as well as the timing, have become clearer. The survey will also be looking for the views of colleagues on how the College has addressed the challenges of Brexit so far.
"It is particularly important that those who responded to last year’s survey do so this year because the aim is to get a sense of how their views and plans are shifting as the Brexit process moves forward."
As with last year’s survey, the views collated through the consultation will help the College understand the immediate and longer-term impact of the UK’s exit from the EU, gather evidence that could be used to make a case for special treatment of veterinary professionals with regard to future immigration policies and allow the College to provide informed advice to European veterinary professionals as they make decisions about their future careers.
Dr Tufnell added: "I would strongly encourage EU veterinary professionals to respond to this survey, even if they didn’t do so last year, as their views really do matter to us and really do have an impact on our Brexit policies and the views we put forward to the government in these critical times."
The deadline for sending responses to the IES is Wednesday 18 July 2018 and all data will be managed and analysed by IES, an independent not-for-profit research institute, on a confidential basis with no individual responses being seen by the RCVS.
The College says it intends to conduct a third survey when the terms of the UK’s withdrawal from the EU, and the impact of this on non-UK EU nationals, are better defined.
Although microchipping has been a legal requirement for dogs since April 2016, it is not currently required for cats unless they are travelling under the Pet Travel Scheme.
Cats Protection says microchipping should become a legal requirement for owned cats and is petitioning for change in the law. At the moment, it says, eight out of ten stray cats taken in by its adoption centres in England are not microchipped, making it virtually impossible to trace the owner.
Cats Protection’s Chief Executive, James Yeates, said: "Introducing compulsory microchipping of owned cats would encourage more cat owners to microchip their cats, meaning that lost cats can be identified and returned home rather than handed into rehoming charities as strays.
"It also means that injured cats can be quickly identified by vets and their owners can be informed and involved in their care.
"We’re delighted the Government has shown a commitment towards improving feline welfare and promoting responsible cat ownership in the UK by announcing this call for evidence."
Environment Secretary, Theresa Villiers, said: "Today’s call for evidence on cat microchipping will help the government understand how we can better protect this country’s much-loved cats and kittens. This government is committed to animal welfare and improving the lives of our companion animals."
The call for evidence will last for 12 weeks and respondents are being encouraged to respond as soon as possible. You can take part here.
The College says its Veterinary Graduate Development Programme (VetGDP), which will be replacing the Professional Development Phase (PDP), has been developed in response to detailed feedback from the profession during the 2018-19 Graduate Outcomes consultation, which looked at how graduates could be better supported during their transition into working life.
One of the main changes will be the introduction of VetGDP Advisers for all new graduates enrolling onto the programme, to provide one-to-one support and advice to help build the confidence and skillsets of new vets.
Practices wanting to employ veterinary graduates from summer 2021 will need to have at least one trained VetGPD Adviser in the workplace. This will involve a short, free online training course and will contribute to their practice being recognised as an RCVS-Approved Graduate Development Practice (for non-clinical settings they will be called RCVS-Approved Graduate Development Employers).
Dr Sue Paterson, Chair of the RCVS Education Committee, said: “When we conducted the Graduate Outcomes consultation, one very clear message that came across from graduates was that they felt there was a need for more bespoke, hands-on and one-to-one guidance from a designated person in their practice.
"The role of VetGDP Adviser is to help graduates identify areas of strength and areas for improvement, to closely monitor and provide feedback on their performance, and to support them in finding their feet as a newly-qualified professional. We hope all this will help increase their confidence and competence and, crucially, ensure we are doing more to retain our young vets in the profession and that this investment in our young talent will, in turn, benefit practices and the profession at large.
“Ahead of the introduction of VetGDP next summer, we want to give the profession advance notice of the coming changes and ask members of the profession who have been on the UK-practising Register for at least three years, and who are passionate about supporting the next generation of vets, to consider becoming VetGDP Advisers.
"We will be introducing free formal online training for VetGDP Advisers from April 2021 but we are asking vets to register their interest as soon as possible so they can find out more about what the role will entail and how it will support new graduates.”
The training will comprise approximately 20 hours of e-learning using a mixture of different methods including case studies, reflective exercises and recorded presentations and will cover topics such as giving effective feedback to support, encourage and motivate; coaching techniques; the provision of guided reflection; goal-setting; reviewing progress; and mentoring.
The training is being provided online by the RCVS and can be undertaken flexibly at any time. It can also count towards the annual continuing professional development (CPD) requirement.
Once an individual has completed the training, and committed to providing the equivalent of at least one hour of support each week per graduate employed, they will receive VetGDP Adviser status. The role will include observing their graduate’s practice and providing feedback and guidance where appropriate.
Veterinary practices with at least one employed VetGDP Adviser will also be formally recognised as an RCVS-Approved Graduate Development Practice, which will indicate that they are able to employ new graduate veterinary surgeons and have the necessary support and development structures in place.
Dr Linda Prescott-Clements, RCVS Director of Education, added: “Developing VetGDP has been a significant step forward in supporting graduates to establish fulfilling veterinary careers. I would like to thank all those members of the Graduate Outcomes Working Group, the Education Committee and RCVS Council who have been involved in putting together the programme, as well as all those veterinary professionals and students whose feedback was crucial in shaping the direction of travel.
“The programme recognises that the profession would like to see a range of ways to support graduates in the workplace, involving a balance between professional and clinical skills. The need was for a programme to reflect their everyday work and professional development in the workplace, with a much greater focus on structured and meaningful support. This support is crucial in developing them beyond their Day-One Competences into becoming confident, capable and independent veterinary professionals.
“As all new vet graduates from summer 2021 will be required to undertake the VetGDP, practices and other workplaces taking on new graduates will need to have at least one VetGDP Adviser and RCVS-Approved Graduate Development Practice status. The online training is not onerous, it is free of charge and takes approximately 20 hours; furthermore, it can be counted towards CPD hourly targets for the year. We envisage that the VetGDP Adviser role will be highly rewarding, with the personal satisfaction of knowing you’re helping to shape and support the next generation of vets.
“Please do make sure to take a look at the full range of resources that we have produced about VetGDP and familiarise yourself with the coming changes.”
To aid understanding of the VetGDP, the RCVS has produced a number of resources, including FAQs, further information for those who are interested in becoming VetGDP Advisers, and information for students, which can be found at: www.rcvs.org.uk/lifelong-learning/vetgdp
From early 2021, the RCVS will be holding online video seminars with final-year veterinary students from all eight UK veterinary schools to discuss VetGDP in further detail.
Anyone with further questions about VetGDP should contact the RCVS Education Department on vetgdp@rcvs.org.uk
Pfizer Animal Health has launched Poulvac, the first modified live vaccine against E.coli in chickens.
The company claims that the vaccine, which can be used from one day of age, is set to bring major benefits in safeguarding the health of broilers, pullets for egg laying and breeding stock.
According to Pfizer, E.coli is one of the most significant bacterial pathogens found in chicks during the first week, leading to problems throughout the life of a flock including inferior performance, lack of uniformity and increased mortality. It is a costly, widespread problem for the UK poultry industry.
The vaccine was developed from research beginning in the 1990s at the Government's veterinary laboratories at Weybridge (now AHVLA) in the UK, employing genome technology to produce an avirulent strain of E.coli that induces protective immunity to the pathogenic strains of the bacteria.
The vaccine is completely non-pathogenic, and does not persist in the bird or the environment for any significant period of time. A gene deletion in its development restricts in vivo replication and leaves behind activated macrophages ready to respond to pathogenic E.coli strains.
Dr Stuart Andrews, poultry technical manager of Pfizer in the UK and Ireland said: "Poulvac E. coli provides broad cross protection against the key serotypes of E. coli infecting chickens. It is the only modified live, nonreactive vaccine proven to meet the European regulatory requirements for efficacy and safety.
"Trials have confirmed that Poulvac E.coli does not persist in the bird and proves to be self-limiting. The vaccine can survive in the environment for only a short time, and spread to in-contact birds is also limited."
The vaccine is administered as a coarse spray with onset of immunity 14 days afterwards and duration of immunity for up to 12 weeks. It can be used from day-old up to six weeks before the onset of lay, and has a nil day withdrawal period.
In the USA where Poulvac E coli has been available for six years field experience has shown the considerable benefits. In the Midwest where average layer mortality at 50 weeks of age was 2.31 per cent, this was reduced to 1.51 per cent with three doses of the vaccine*. In Eastern USA flock mortality compared with five previous flocks was reduced from over three per cent to one per cent.
A field trial in the USA with more than 300,000 broiler breeders vaccination before lay reduced mortality from 2.8 to 1.9 per cent - with only two out of 28 flocks needing antibiotic treatment compared with 13 of the 28 unvaccinated flocks.
On a broiler field trial in Georgia over four million birds were vaccinated with Poulvac E. coli at hatch. The vaccinated birds had a better feed conversion (1.79 against 1.84 for the controls) and with condemnations at the processing plant down from 1.22 to 0.73 per cent the result was a lower production cost of 0.51¢ per lb.
In another broiler trial covering more than two million birds in Arkansas livability was improved from 95.20 to 95.77 per cent and feed conversion improved from 1.95 to 1.90, gaining 0.45¢ per lb.
* Pfizer says it is important to note that in these studies carried out in the USA more than one dose of the vaccine was often administered. A single vaccination is licensed in the Summary of Product Characteristics however, where clinical disease requires and at the discretion of a veterinary surgeon, the vaccination schedule may be re-started as there is no contra-indication on the SPC.
Woodley Equipment has launched ImmunoComb diganostic test kits for FIP, canine Leptospira and Ehrlichia
Woodley says the kits are easy to use and provide results within 20 minutes. No specialist laboratory equipment is required as the kits are self-contained with all the necessary reagents. The diagnostic kits determine the animal's antibody titre levels, in the case of the canine Ehrlichia as early as 7 days after infection, giving veterinary surgeons the opportunity to act more quickly in developing a prevention/treatment program.
Tests can be performed singly or up to 12 simultaneously.
For more information about ImmunoComb Diagnostic kits email sales@woodleyequipment.com or call: +44 (0) 1204 669033 Option 1. Alternatively visit http://www.woodleyequipment.com/
The kit uses an indirect semi-quantitative IgG antibody assay which provides an easy-to-read colour change which clearly distinguishes normal IgG levels (>8mg/ml; colourless), partial FPT (4-8mg/ml; pink) and levels generally considered diagnostic of complete FPT (<4mg/ml; purple).
Vetlabs says the kit has a proven sensitivity and specificity of 97.4% and 93.6% respectively, and responds equally well with anticoagulant whole blood, serum or plasma. And with no additional equipment or refrigerated storage required, it is a true field test.
Mike Fleming, CEO of Vetlab Supplies Ltd said: "It’s not often you get to launch an equine diagnostic that’s genuinely life saving. With Fastest IgG Equine, vets can now give a clear-cut Failure of Passive Transfer (FPT) diagnosis at farms, stables or equestrian centres – and all in just 10 minutes."
According to the company, as many as 1 in 5 new-born foals can suffer some degree of IgG FPT. Foals with no antibody protection, due to complete FTP, have an estimated 75% chance of contracting debilitating or life-threatening infection. Even foals with some protection following partial FPT have only a 50% chance of resisting invaders such as Anaplasma, Giardia and Cryptosporidium.
The new-born foal’s absorption of maternal antibodies is most efficient in the first 6 to 8 hours of life, effectively ceasing after 24 to 36 hours. Veterinary surgeons and managers of equestrian facilities have only this narrow window to recognise FPT and act to save a valuable new-born from life threatening infection.
Mike added: "With Fastest Equine as part of their field kit, equine vets are equipped to diagnose and treat antibody deficient foals with life-saving colostrum, colsotrum formula substitute, or administer oral or intravenous IgG, within that critical first 24 hours."